Transcatheter Intra-arterial Perfusion (TRIP)-MRI Biomarkers Help Detect Immediate Response to Irreversible Electroporation of Rabbit VX2 Liver Tumor

Overview

Journal Magn Reson Med

Publisher Wiley

Specialty Radiology

Date 2019 Dec 19

PMID 31850550

Citations 7

Authors

Matteo Figini

Kang Zhou

Liang Pan

Chong Sun

Bin Wang

Su Hu

Jia Yang

Junjie Shangguan

Aydin Eresen

Yury Velichko

Vahid Yaghmai

Zhuoli Zhang

Affiliations

Soon will be listed here.

Abstract

Purpose: Irreversible electroporation (IRE) is a nonthermal tissue ablation technique that represents a promising treatment option for unresectable liver tumors, but the effectively treated zone cannot be reliably predicted. We investigate the potential benefit of transcatheter intra-arterial perfusion (TRIP) -MRI for the early noninvasive differentiation of IRE zone from surrounding reversibly electroporated (RE) zone.

Methods: Seventeen rabbits with VX2 liver tumors were scanned with morphological and contrast-enhanced MRI sequences approximately 30 min after IRE tumor ablation. Quantitative TRIP-MRI perfusion parameters were evaluated in IRE zone and RE zone, defined according to histology. MRI and histology results were compared among zones using Wilcoxon rank-sum tests and correlations were evaluated by Pearson's correlation coefficient.

Results: There were significant differences in area under the curve, time to peak, maximum and late enhancement, wash-in and wash-out rates in the tumor IRE zones compared with the boundary tumor RE zones and untreated tumors. Histology showed significantly fewer tumor cells, microvessels and significantly more apoptosis in tumor IRE zones compared with tumor RE zones (-51%, -66% and +185%, respectively) and untreated tumors (-60%, -67%, and +228%, respectively). A strong correlation was observed between MRI and histology measurements of IRE zones (r = 0.948) and RE zones (r = 0.951).

Conclusion: TRIP-MRI demonstrated the potential to detect immediate perfusion changes following IRE liver tumor ablation and effectively differentiate the IRE zone from the surrounding tumor RE zone.

Citing Articles

Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review.

Zhang Z, Yu G, Eresen A, Chen Z, Yu Z, Yaghmai V Ann Transl Med. 2024; 12(4):77.

PMID: 39118942 PMC: 11304422. DOI: 10.21037/atm-23-1882.

Early assessment of irreversible electroporation ablation outcomes by analyzing MRI texture: preclinical study in an animal model of liver tumor.

Eresen A, Zhou K, Sun C, Shangguan J, Wang B, Pan L Am J Transl Res. 2022; 14(8):5541-5551.

PMID: 36105031 PMC: 9452330.

Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology, Histology, and Tumor Microenvironment Characteristics.

Pascale F, Pelage J, Wassef M, Ghegediban S, Saint-Maurice J, De Baere T Front Oncol. 2022; 12:871829.

PMID: 35619923 PMC: 9128410. DOI: 10.3389/fonc.2022.871829.

Early Differentiation of Irreversible Electroporation Ablation Regions With Radiomics Features of Conventional MRI.

Eresen A, Sun C, Zhou K, Shangguan J, Wang B, Pan L Acad Radiol. 2021; 29(9):1378-1386.

PMID: 34933803 PMC: 10029937. DOI: 10.1016/j.acra.2021.11.020.

Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma.

Eresen A, Yang J, Scotti A, Cai K, Yaghmai V, Zhang Z Ann Transl Med. 2021; 9(13):1089.

PMID: 34423001 PMC: 8339821. DOI: 10.21037/atm-21-539.

References

Chung D, Sung K, Osuagwu F, Wu H, Lassman C, Lu D . Contrast Enhancement Patterns after Irreversible Electroporation: Experimental Study of CT Perfusion Correlated to Histopathology in Normal Porcine Liver. J Vasc Interv Radiol. 2015; 27(1):104-11. DOI: 10.1016/j.jvir.2015.09.005. View

Chen X, Ren Z, Zhu T, Zhang X, Peng Z, Xie H . Electric Ablation with Irreversible Electroporation (IRE) in Vital Hepatic Structures and Follow-up Investigation. Sci Rep. 2015; 5:16233. PMC: 4637899. DOI: 10.1038/srep16233. View

Figini M, Wang X, Lyu T, Su Z, Wang B, Sun C . Diffusion MRI biomarkers predict the outcome of irreversible electroporation in a pancreatic tumor mouse model. Am J Cancer Res. 2018; 8(8):1615-1623. PMC: 6129492. View

Lopez-Alonso B, Hernaez A, Sarnago H, Naval A, Guemes A, Junquera C . Histopathological and Ultrastructural Changes after Electroporation in Pig Liver Using Parallel-Plate Electrodes and High-Performance Generator. Sci Rep. 2019; 9(1):2647. PMC: 6389957. DOI: 10.1038/s41598-019-39433-6. View

corovic S, Lackovic I, Sustaric P, Sustar T, Rodic T, Miklavcic D . Modeling of electric field distribution in tissues during electroporation. Biomed Eng Online. 2013; 12:16. PMC: 3614452. DOI: 10.1186/1475-925X-12-16. View

Wang D, Jin B, Lewandowski R, Ryu R, Sato K, Mulcahy M . Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma. J Magn Reson Imaging. 2010; 31(5):1106-16. PMC: 2885358. DOI: 10.1002/jmri.22155. View

Valerio M, Stricker P, Ahmed H, Dickinson L, Ponsky L, Shnier R . Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2014; 17(4):343-7. PMC: 4227889. DOI: 10.1038/pcan.2014.33. View

Davalos R, Mir I, Rubinsky B . Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005; 33(2):223-31. DOI: 10.1007/s10439-005-8981-8. View

Wells S, Hinshaw J, Lubner M, Ziemlewicz T, Brace C, Lee Jr F . Liver Ablation: Best Practice. Radiol Clin North Am. 2015; 53(5):933-71. PMC: 6419975. DOI: 10.1016/j.rcl.2015.05.012. View

10.

Lencioni R, Crocetti L . Local-regional treatment of hepatocellular carcinoma. Radiology. 2011; 262(1):43-58. DOI: 10.1148/radiol.11110144. View

11.

Distelmaier M, Barabasch A, Heil P, Kraemer N, Isfort P, Keil S . Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins. Radiology. 2017; 285(3):1023-1031. DOI: 10.1148/radiol.2017161561. View

12.

Lee Y, Lu D, Osuagwu F, Lassman C . Irreversible electroporation in porcine liver: short- and long-term effect on the hepatic veins and adjacent tissue by CT with pathological correlation. Invest Radiol. 2012; 47(11):671-5. DOI: 10.1097/RLI.0b013e318274b0df. View

13.

Jiang C, Davalos R, Bischof J . A review of basic to clinical studies of irreversible electroporation therapy. IEEE Trans Biomed Eng. 2014; 62(1):4-20. DOI: 10.1109/TBME.2014.2367543. View

14.

Maor E, Ivorra A, Leor J, Rubinsky B . The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat. 2007; 6(4):307-12. DOI: 10.1177/153303460700600407. View

15.

Gervais D, Goldberg S, Brown D, Soulen M, Millward S, Rajan D . Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J Vasc Interv Radiol. 2008; 20(1):3-8. DOI: 10.1016/j.jvir.2008.09.007. View

16.

Wang D, Gaba R, Jin B, Riaz A, Lewandowski R, Ryu R . Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma. Acad Radiol. 2011; 18(7):828-36. PMC: 3169325. DOI: 10.1016/j.acra.2011.02.016. View

17.

Bhutiani N, Agle S, Li Y, Li S, Martin 2nd R . Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma. J Surg Oncol. 2016; 114(2):181-6. DOI: 10.1002/jso.24288. View

18.

Rossmeisl Jr J, Garcia P, Pancotto T, Robertson J, Henao-Guerrero N, Neal 2nd R . Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas. J Neurosurg. 2015; 123(4):1008-25. DOI: 10.3171/2014.12.JNS141768. View

19.

Sutter O, Calvo J, Nkontchou G, Nault J, Ourabia R, Nahon P . Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series. Radiology. 2017; 284(3):877-886. DOI: 10.1148/radiol.2017161413. View

20.

Scheffer H, Nielsen K, de Jong M, van Tilborg A, Vieveen J, Bouwman A . Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy. J Vasc Interv Radiol. 2014; 25(7):997-1011. DOI: 10.1016/j.jvir.2014.01.028. View